Search This Site:
Clinical Commissioning Groups Logo

Prescribing Information & Guidance

Ranibizumab or Bevacizumab for the Treatment of Juxtafoveal Telangiectasia

Guideline added to website on: 10/06/20
Last modified on: 05/11/20
CCG: |
Tags: bevacizumab, juxtafoveal telangiectasia, ranibizumab

Under review - Contact Medicine Management team at for details

Bulletin 211- Published Feb 15
Posted in
Scroll to Top